D. J. Hunter, P. Kraft, K. B. Jacobs, D. G. Cox, M. Yeager et al., A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer, Nature Genetics, vol.164, issue.7
DOI : 10.1371/journal.pgen.0020190

K. Michailidou, J. Beesley, S. Lindstrom, S. Canisius, J. Dennis et al., Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer, Nature Genetics, vol.490, issue.4, pp.373-380, 2015.
DOI : 10.1038/ng.3242

A. Siddiq, F. J. Couch, G. K. Chen, S. Lindström, D. Eccles et al., A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11, Human Molecular Genetics, vol.21, issue.24
DOI : 10.1093/hmg/dds381

C. A. Haiman, G. K. Chen, C. M. Vachon, F. Canzian, A. Dunning et al., A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor???negative breast cancer, Nature Genetics, vol.43, issue.12
DOI : 10.1038/ng.666

J. D. Figueroa, M. Garcia-closas, M. Humphries, R. Platte, J. L. Hopper et al., Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium, Human Molecular Genetics, vol.20, issue.23, pp.4693-4706, 2011.
DOI : 10.1093/hmg/ddr368

K. N. Stevens, Z. Fredericksen, C. M. Vachon, X. Wang, S. Margolin et al., 19p13.1 Is a Triple-Negative-Specific Breast Cancer Susceptibility Locus, Cancer Research, vol.72, issue.7, pp.1795-1803, 2012.
DOI : 10.1158/0008-5472.CAN-11-3364

M. Garcia-closas, F. J. Couch, S. Lindstrom, K. Michailidou, M. Schmidt et al., Genome-wide association studies identify four ER negative???specific breast cancer risk loci, Nature Genetics, vol.9, issue.4, pp.392-398, 2013.
DOI : 10.1093/nar/gks542

D. Lambrechts, T. Truong, C. Justenhoven, M. K. Humphreys, J. Wang et al., 11q13 is a susceptibility locus for hormone receptor positive breast cancer, Human Mutation, vol.9, issue.7, pp.1123-1132, 2012.
DOI : 10.1002/humu.22089

K. S. Purrington, S. Slager, D. Eccles, D. Yannoukakos, P. A. Fasching et al., Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer, Carcinogenesis, vol.35, issue.5, pp.1012-1019, 2014.
DOI : 10.1093/carcin/bgt404

H. Warren, F. Dudbridge, O. Fletcher, N. Orr, N. Johnson et al., 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium, Cancer Epidemiology Biomarkers & Prevention, vol.21, issue.10
DOI : 10.1158/1055-9965.EPI-12-0526

K. N. Stevens, C. M. Vachon, A. M. Lee, S. Slager, T. Lesnick et al., Common Breast Cancer Susceptibility Loci Are Associated with Triple-Negative Breast Cancer, Cancer Research, vol.71, issue.19, pp.6240-6249, 2011.
DOI : 10.1158/0008-5472.CAN-11-1266

A. Broeks, M. K. Schmidt, M. E. Sherman, F. J. Couch, H. L. Hopper et al., Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium, Human Molecular Genetics, vol.20, issue.16, pp.3289-3303, 2011.
DOI : 10.1093/hmg/ddr228

Y. Cen, M. Qi, H. Li, Y. Su, L. Chen et al., with breast cancer risk by estrogen/progesterone receptor status, Molecular Carcinogenesis, vol.13, issue.S1, pp.52-59, 2013.
DOI : 10.1002/mc.21979

X. Pivot, G. Romieu, M. Debled, J. Pierga, P. Kerbrat et al., et al. 6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial

Y. S. Aulchenko, M. V. Struchalin, and C. M. Van-duijn, ProbABEL package for genome-wide association analysis of imputed data, BMC Bioinformatics, vol.11, issue.1, p.134, 2010.
DOI : 10.1186/1471-2105-11-134

X. Goa, L. C. Becker, D. M. Becker, J. D. Starmer, and M. A. Province, Avoiding the high Bonferroni penalty in genome-wide association studies, Genet. Epidemiol, vol.34, pp.100-105, 2010.

K. B. Meyer, M. O-'reilly, K. Michailidou, C. Saskia, S. L. Edwards et al., Fine-Scale Mapping of the FGFR2 Breast Cancer Risk Locus: Putative Functional Variants Differentially Bind FOXA1 and E2F1, The American Journal of Human Genetics, vol.93, issue.6, pp.1046-1060, 2013.
DOI : 10.1016/j.ajhg.2013.10.026